Human BLVRB was also shown to be an NRF2 target gene: both KEAP1 knockdown and treatment with 15 μM sulforaphane induced BLVRB transcripts one- to threefold in breast cancer MCF10A cells (1). The gene discussed is BLVRB; the disease is breast cancer.